Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Léčba obrovskobuněčného kostního nádoru distálního radia a ulny
[Treatment of Giant Cell Tumor of Bone in the Distal Radius and Ulna]

M. Mahdal, J. Jindra, I. Staniczková Zambo, L. Pazourek, L. Nachtnebl, T. Tomáš

. 2022 ; 89 (3) : 188-192.

Jazyk čeština Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22016370

Digitální knihovna NLK
Zdroj

E-zdroje NLK Online

Free Medical Journals od 2006

PURPOSE OF THE STUDY The preferred treatment of giant cell tumor of bone is curettage with the use of local adjuvant. If the tumor spreads beyond the bone into soft tissues, en bloc excision should be performed. Intralesional curettage allows joint preservation, but it is associated with a high recurrence rate. The purpose of the study was to identify the risk factors for local recurrence and to compare the functional outcomes after both types of surgical procedures. MATERIAL AND METHODS The group included 16 patients (5 women, 11 men) with giant cell tumor of bone in distal forearm treated at the First Department of Orthopedic Surgery, St. Anne s University Hospital Brno in 2005-2019. The mean age of patients was 38 years (22-53). The follow-up period was 6.75 years (2-15) on average. The most common location of the tumor was distal radius (14). In 6 patients denosumab treatment was indicated. Based on the obtained data, we compared the effects of gender, Campanacci grade, type of surgery and administration of denosumab on the risk of local recurrence. The functional outcomes were evaluated retrospectively based on the Musculoskeletal Tumor Society scoring system for upper limb salvage surgeries. RESULTS Resection and reconstruction using an osteocartilaginous allograft was performed in 9 patients. Seven patients were treated with tumor curettage with bone cement used to fill the cavity. The group of patients who underwent curettage showed a significantly higher mean MSTS score 89% compared to the group of patients with resection with the mean MSTS score 66% (P < 0.05). Local tumor recurrence was reported in 3 patients (18.75%). No statistically significant difference was found in gender, tumor grade, radicality of surgery or administration of targeted therapy with respect to the incidence of local recurrence. Altogether 6 complications (37.5%) were observed in the group. DISCUSSION The treatment of a giant cell tumor of bone aims to completely remove the tumor and to preserve the best possible function of the limb. The complications in distal forearm involve particularly an increase incidence of local recurrence and painful or limited range of motion of the wrist. Whereas curettage with the use of local adjuvant is burdened with a higher recurrence rate, resection with allograft reconstruction of bone defect is usually associated with poorer functional outcomes. CONCLUSIONS Tumor curettage using local adjuvant is preferred in a well-circumscribed tumor and offers an excellent functional outcome. En bloc tumor resection and reconstruction using an osteocartilaginous allograft is a suitable treatment option for a locally advanced tumor with a low risk of local recurrence. Key words: giant cell tumor of bone, distal radius, distal ulna, curettage, osteocartilaginous allograft.

Treatment of Giant Cell Tumor of Bone in the Distal Radius and Ulna

000      
00000naa a2200000 a 4500
001      
bmc22016370
003      
CZ-PrNML
005      
20230224085007.0
007      
ta
008      
220714s2022 xr ad f 000 0|cze||
009      
AR
035    __
$a (PubMed)35815484
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Mahdal, Michal $u I. ortopedická klinika Fakultní nemocnice u sv. Anny v Brně, Lékařská fakulta Masarykovy univerzity, Brno $7 xx0254094
245    10
$a Léčba obrovskobuněčného kostního nádoru distálního radia a ulny / $c M. Mahdal, J. Jindra, I. Staniczková Zambo, L. Pazourek, L. Nachtnebl, T. Tomáš
246    31
$a [Treatment of Giant Cell Tumor of Bone in the Distal Radius and Ulna]
520    9_
$a PURPOSE OF THE STUDY The preferred treatment of giant cell tumor of bone is curettage with the use of local adjuvant. If the tumor spreads beyond the bone into soft tissues, en bloc excision should be performed. Intralesional curettage allows joint preservation, but it is associated with a high recurrence rate. The purpose of the study was to identify the risk factors for local recurrence and to compare the functional outcomes after both types of surgical procedures. MATERIAL AND METHODS The group included 16 patients (5 women, 11 men) with giant cell tumor of bone in distal forearm treated at the First Department of Orthopedic Surgery, St. Anne s University Hospital Brno in 2005-2019. The mean age of patients was 38 years (22-53). The follow-up period was 6.75 years (2-15) on average. The most common location of the tumor was distal radius (14). In 6 patients denosumab treatment was indicated. Based on the obtained data, we compared the effects of gender, Campanacci grade, type of surgery and administration of denosumab on the risk of local recurrence. The functional outcomes were evaluated retrospectively based on the Musculoskeletal Tumor Society scoring system for upper limb salvage surgeries. RESULTS Resection and reconstruction using an osteocartilaginous allograft was performed in 9 patients. Seven patients were treated with tumor curettage with bone cement used to fill the cavity. The group of patients who underwent curettage showed a significantly higher mean MSTS score 89% compared to the group of patients with resection with the mean MSTS score 66% (P < 0.05). Local tumor recurrence was reported in 3 patients (18.75%). No statistically significant difference was found in gender, tumor grade, radicality of surgery or administration of targeted therapy with respect to the incidence of local recurrence. Altogether 6 complications (37.5%) were observed in the group. DISCUSSION The treatment of a giant cell tumor of bone aims to completely remove the tumor and to preserve the best possible function of the limb. The complications in distal forearm involve particularly an increase incidence of local recurrence and painful or limited range of motion of the wrist. Whereas curettage with the use of local adjuvant is burdened with a higher recurrence rate, resection with allograft reconstruction of bone defect is usually associated with poorer functional outcomes. CONCLUSIONS Tumor curettage using local adjuvant is preferred in a well-circumscribed tumor and offers an excellent functional outcome. En bloc tumor resection and reconstruction using an osteocartilaginous allograft is a suitable treatment option for a locally advanced tumor with a low risk of local recurrence. Key words: giant cell tumor of bone, distal radius, distal ulna, curettage, osteocartilaginous allograft.
650    _2
$a dospělí $7 D000328
650    12
$a nádory kostí $x patologie $7 D001859
650    _2
$a denosumab $7 D000069448
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    12
$a obrovskobuněčný nádor kosti $x patologie $x chirurgie $7 D018212
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a radius $x chirurgie $7 D011884
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a výsledek terapie $7 D016896
650    _2
$a ulna $x patologie $x chirurgie $7 D014457
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jindra, Jakub $u I. ortopedická klinika Fakultní nemocnice u sv. Anny v Brně, Lékařská fakulta Masarykovy univerzity, Brno $7 xx0277027
700    1_
$a Zambo, Iva $u Ústav patologie, Fakultní nemocnice u sv. Anny v Brně, Lékařská fakulta Masarykovy univerzity, Brno $7 xx0211296
700    1_
$a Pazourek, Lukáš $u I. ortopedická klinika Fakultní nemocnice u sv. Anny v Brně, Lékařská fakulta Masarykovy univerzity, Brno $7 xx0123254
700    1_
$a Nachtnebl, Luboš $u I. ortopedická klinika Fakultní nemocnice u sv. Anny v Brně, Lékařská fakulta Masarykovy univerzity, Brno $7 xx0106708
700    1_
$a Tomáš, Tomáš, $u I. ortopedická klinika Fakultní nemocnice u sv. Anny v Brně, Lékařská fakulta Masarykovy univerzity, Brno $d 1968- $7 ola2006319238
773    0_
$w MED00011021 $t Acta chirurgiae orthopaedicae et traumatologiae Čechoslovaca $x 0001-5415 $g Roč. 89, č. 3 (2022), s. 188-192
856    41
$u https://achot.cz/pdfs/ach/2022/03/02.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 8 $c 507 $y p $z 0
990    __
$a 20220714 $b ABA008
991    __
$a 20230224084959 $b ABA008
999    __
$a ok $b bmc $g 1825265 $s 1167612
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 89 $c 3 $d 188-192 $e $i 0001-5415 $m Acta chirurgiae orthopaedicae et traumatologiae Čechoslovaca $n Acta chir. orthop. traumatol. Čechoslovaca $x MED00011021
LZP    __
$b NLK198 $a Pubmed-20220714

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...